Global Biopharmaceutical Company v. Large Health Benefit Manager

Represented one of the world’s largest biopharmaceutical companies in a complex breach of contract action.

Our client, one of the largest biopharmaceutical companies in the world, sought claims in excess of $52 million related to the defendant’s formulary management for some of the largest sponsored health plans in the country. The breaches at issue were directly relevant to ongoing tensions and business practices that impact a multibillion-dollar commercial relationship between two of the largest players in the pharmaceutical industry.

The Willenken team deftly negotiated and reached a favorable and confidential settlement for our client.

up next...

David Cassirer v. Thyssen-Bornemisza Collection Foundation

June 1, 2019